ABEV vs FMX

ABEV's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock trades above the Graham Number of $2.24 at a current price of $2.78, suggesting modest overvaluation for a defensive stock, though below the growth-based intrinsic value of $5.9. Strong profitability metrics like a 17.73% profit margin and 26.01% operating margin are offset by declining revenue growth of -5.70% YoY and a concerning 104.3% dividend payout ratio. Analysts rate it a 'hold' with a $2.93 target, implying limited upside.

FMX demonstrates strong operational health with a Piotroski F-Score of 7/9, but this is overshadowed by severe valuation concerns and unsustainable capital returns. The stock is trading at a significant premium to its Graham Number ($52.24) and Intrinsic Value ($87.91), with a PEG ratio of 6.46 indicating extreme overvaluation relative to growth. Most critically, the dividend payout ratio of 201.08% is unsustainable, and the company has failed to beat earnings estimates in the last four consecutive quarters. Despite a 'buy' analyst consensus, the combination of bearish technicals (10/100) and deteriorating earnings surprises suggests a high risk of correction.